These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Neutrophil gelatinase-associated lipocalin is a new and sensitive marker of kidney function in chronic kidney disease patients and renal allograft recipients. Malyszko J, Malyszko JS, Bachorzewska-Gajewska H, Poniatowski B, Dobrzycki S, Mysliwiec M. Transplant Proc; 2009; 41(1):158-61. PubMed ID: 19249502 [Abstract] [Full Text] [Related]
12. Admission plasma neutrophil gelatinase associated lipocalin (NGAL) predicts worsening renal function during hospitalization and post discharge outcome in patients with acute heart failure. Palazzuoli A, Ruocco G, Beltrami M, Franci B, Pellegrini M, Lucani B, Nuti R, Ronco C. Acute Card Care; 2014 Sep; 16(3):93-101. PubMed ID: 24836558 [Abstract] [Full Text] [Related]
13. Kidney function assessed by eGFR, cystatin C and NGAL (neutrophil gelatinase-associated lipocalin) in relation to age in heart allograft recipients. Przybylowski P, Malyszko J, Malyszko J. Med Sci Monit; 2010 Sep; 16(9):CR440-4. PubMed ID: 20802417 [Abstract] [Full Text] [Related]
16. Comparative assessment of neutrophil gelatinase-associated lipocalin (NGAL) and cystatin C as early biomarkers for early detection of renal failure in patients with hypertension. Gharishvandi F, Kazerouni F, Ghanei E, Rahimipour A, Nasiri M. Iran Biomed J; 2015 Sep; 19(2):76-81. PubMed ID: 25864811 [Abstract] [Full Text] [Related]
17. Early diagnostic markers for contrast nephropathy in patients undergoing coronary angiography. Shaker OG, El-Shehaby A, El-Khatib M. Angiology; 2010 Nov; 61(8):731-6. PubMed ID: 20529972 [Abstract] [Full Text] [Related]